ImCure Therapeutics Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

ImCure Therapeutics General Information

Description

Developer of cardiovascular and arthritis treatments. The company develops drugs and other water-soluble cholesterol altering compounds for treating cardiovascular and arthritis problems as well as cancer and tuberculosis.

Contact Information

Website
www.imcureinc.com
Formerly Known As
JJ Pharma
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 9000 Crow Canyon Road
  • Suite S, Number 195
  • Danville, CA 94506
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 9000 Crow Canyon Road
  • Suite S, Number 195
  • Danville, CA 94506
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImCure Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business Completed Out of Business
3. Early Stage VC 15-Dec-2009 Completed Startup
2. Early Stage VC 08-Mar-2007 $480K $2.96M Completed Startup
1. Early Stage VC 02-Feb-2007 $2.48M $2.48M Completed Startup
To view ImCure Therapeutics’s complete valuation and funding history, request access »

ImCure Therapeutics Patents

  • 17

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

ImCure Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20080269231-A1 Water soluble drugs; antiarthritic agents Inactive 16-Jan-2007
AU-2008206218-A1 Phenazine compounds and use thereof in autoimmune and inflammatory diseases Inactive 16-Jan-2007
US-8273881-B2 Phenazine compounds and use thereof in autoimmune and inflammatory diseases Inactive 16-Jan-2007
CA-2675743-A1 Phenazine compounds and use thereof in autoimmune and inflammatory diseases Inactive 16-Jan-2007
US-20100190799-A1 Phenazine compounds and use thereof in autoimmune and inflammatory diseases Active 16-Jan-2007 C07D241/52
To view ImCure Therapeutics’s complete patent history, request access »

Ready to get started?

Request a free trial

ImCure Therapeutics FAQs

  • When was ImCure Therapeutics founded?

    ImCure Therapeutics was founded in 2004.

  • Where is ImCure Therapeutics headquartered?

    ImCure Therapeutics is headquartered in Danville, CA.

  • What industry is ImCure Therapeutics in?

    ImCure Therapeutics’s primary industry is Biotechnology.

  • Is ImCure Therapeutics a private or public company?

    ImCure Therapeutics is a Private company.

  • What is ImCure Therapeutics’s current revenue?

    The current revenue for ImCure Therapeutics is .

  • How much funding has ImCure Therapeutics raised over time?

    ImCure Therapeutics has raised $3.22M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »